Manuel Ascano

Manuel Ascano, associate professor of biochemistry and pathology, microbiology and immunology, and Dr. Alissa Weaver, Cornelius Vanderbilt Chair and director of the Vanderbilt Center for Extracellular Vesicle Research, are one of nine U.S. research teams awarded funding from the National Science Foundation to more fully understand the potential biotechnological uses of RNA, ranging from crop disease protection to treatments that combat cancer. Read More

Thirteen outstanding faculty members from across the university have been selected for the 2023 cohort of Chancellor Faculty Fellows. The group is composed of highly accomplished, recently tenured faculty from a wide variety of disciplines and areas of expertise.   Read More

How does climate change affect human health? How are animals and ecosystems similarly influenced, and how are these impacts interconnected? Join Charles Sanders, associate dean for research and professor of biochemistry, as he delves into these questions and more during the next Lab-to-Table Conversation from the Vanderbilt University School of Medicine Basic Sciences. Read More

Manuel Ascano, assistant professor of biochemistry and pathology, microbiology and immunology, discusses the challenges scientists face when researching which virus may cause the next pandemic. Read More

Manuel Ascano team validates an inhibitor of the cGAS-STING signaling pathway, which is important for cellular innate immunity against bacteria, viruses, and our own damaged DNA. Read More

Researchers have developed a method to identify the primary interactions between incoming viral RNA genomes and host proteins. Read More

The School of Medicine Basic Sciences has established a new Dean’s Faculty Fellows program designed to recognize the efforts of faculty in the early stages of their careers. Read More

Interim Chancellor and Provost Susan R. Wente has established a new Public Health Advisory Task Force to serve as a resource for the university during the COVID-19 pandemic. Read More

Vanderbilt investigators have discovered a class of compounds that inhibit a mediator of inflammation and autoimmune disorders, and that could pave the way for development of future therapies. Read More

Ebola. Chikungunya. Influenza. What’s to be done about these headline-grabbing, debilitating, often lethal viruses? Read More